SQ-32014

ID: ALA4799859

Chembl Id: CHEMBL4799859

PubChem CID: 135535873

Max Phase: Preclinical

Molecular Formula: C6H10N2O2

Molecular Weight: 142.16

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O/N=C1/CCCC/C1=N\O

Standard InChI:  InChI=1S/C6H10N2O2/c9-7-5-3-1-2-4-6(5)8-10/h9-10H,1-4H2/b7-5-,8-6+

Standard InChI Key:  CUNNCKOPAWXYDX-CGXWXWIYSA-N

Alternative Forms

  1. Parent:

    ALA4799859

    ---

Associated Targets(non-human)

SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 142.16Molecular Weight (Monoisotopic): 142.0742AlogP: 1.22#Rotatable Bonds: 0
Polar Surface Area: 65.18Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.51CX Basic pKa: CX LogP: 1.35CX LogD: 1.35
Aromatic Rings: 0Heavy Atoms: 10QED Weighted: 0.39Np Likeness Score: -0.02

References

1. Ellen Van Damme.  (2021)  Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity,  [10.6019/CHEMBL4651402]

Source